Mobix Labs Finalizes Registration of 3.74M Shares for Resale — 25% Dilution Overhang Now Live

summarizeSummary

Mobix Labs' final prospectus makes 3.74 million shares eligible for immediate resale, representing about 25% dilution. The selling stockholders can now sell into the market, adding significant pressure to a stock already battered by going concern doubts and a history of toxic financings.

check_boxKey Events · Financing and Capital Events · MOBX

• 3.74M Share Resale Registration Effective

  The final prospectus registers 3,744,161 shares for resale by selling stockholders, representing approximately 25% of outstanding Class A Common Stock as of June 8, 2026. The shares are now freely tradable.

• No Proceeds to Company from Resales

  Mobix Labs will not receive any proceeds from the sale of these shares. The company may receive up to $6 million if the Preferred Warrant is exercised, but that would trigger additional dilution.

• Toxic Preferred Stock Conversion Shares Included

  Up to 2,000,000 shares are issuable upon conversion of Series A 10% Convertible Preferred Stock and exercise of the Preferred Warrant, held by Kips Bay Select. The conversion price is 82% of the lowest 8-day VWAP, a deeply dilutive structure.

• Debt, Litigation, and Earnout Shares Add to Overhang

  The registration includes 1,207,942 shares issued to lenders to settle debt, 71,267 shares for litigation settlement, and 464,952 earnout shares from the RaGE Systems acquisition — all now eligible for sale.

auto_awesomeAnalysis · MOBX · Manufacturing

This final prospectus activates the resale registration for 3.74 million shares, roughly 25% of the company's outstanding stock. The selling stockholders—a toxic preferred holder, debt-to-equity lenders, litigation counterparties, and earnout recipients—can now sell into the market. While the company receives no proceeds from these sales, the overhang is substantial for a micro-cap already carrying a going concern warning and a stock price near $2. The filing also confirms that up to $6 million could flow to the company if the Preferred Warrant is exercised, but that would bring further dilution. Against a backdrop of repeated dilutive financings and a recent reverse split, this prospectus turns a previously disclosed registration into an immediate market risk.